Elevance HealthELV
ELV
About: Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Employees: 104,200
0
Funds holding %
of 7,296 funds
0
Analysts bullish %
of 7 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
57% more first-time investments, than exits
New positions opened: 214 | Existing positions closed: 136
36% more call options, than puts
Call options by funds: $801M | Put options by funds: $588M
23% more repeat investments, than reductions
Existing positions increased: 643 | Existing positions reduced: 523
16% more funds holding in top 10
Funds holding in top 10: 37 [Q4 2024] → 43 (+6) [Q1 2025]
14% more capital invested
Capital invested by funds: $75.9B [Q4 2024] → $86.9B (+$10.9B) [Q1 2025]
3% more funds holding
Funds holding: 1,571 [Q4 2024] → 1,619 (+48) [Q1 2025]
0.93% less ownership
Funds ownership: 88.85% [Q4 2024] → 87.93% (-0.93%) [Q1 2025]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$478
24%
upside
Avg. target
$499
30%
upside
High target
$529
38%
upside
7 analyst ratings
6 positive
86%
1 neutral
14%
0 negative
0%
Truist Securities David Macdonald | 30%upside $500 | Buy Maintained | 9 Jun 2025 |
RBC Capital Ben Hendrix | 24%upside $478 | Outperform Reiterated | 4 Jun 2025 |
Barclays Andrew Mok | 25%upside $480 | Overweight Maintained | 2 Jun 2025 |
Guggenheim Jason Cassorla | 35%upside $518 | Buy Reiterated | 23 Apr 2025 |
Cantor Fitzgerald Sarah James | 26%upside $485 | Overweight Reiterated | 23 Apr 2025 |
Financial journalist opinion
Based on 154 articles about ELV published over the past 30 days
Neutral
Accesswire
18 hours ago
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ELV
NEW YORK CITY, NY / ACCESS Newswire / June 14, 2025 / WHY: New York, N.Y., June 14, 2025.
Neutral
GlobeNewsWire
21 hours ago
ELV SHAREHOLDERS: Elevance Health, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 11 Deadline (NYSE:ELV)
NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.
Neutral
Accesswire
1 day ago
ELV CLASS ACTION NOTICE: Elevance Health, Inc. Was Sued for Securities Fraud; Contact BFA Law if You Suffered Losses
NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.
Neutral
Accesswire
1 day ago
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ELV
NEW YORK, NY / ACCESS Newswire / June 13, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE:ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period"), of the important July 11, 2025 lead plaintiff deadline. SO WHAT: If you purchased Elevance common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Neutral
Accesswire
1 day ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE:ELV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Neutral
GlobeNewsWire
1 day ago
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., June 14, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.
Neutral
Accesswire
1 day ago
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Elevance securities between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period").
Neutral
GlobeNewsWire
2 days ago
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options
Neutral
Accesswire
2 days ago
ELV CLASS ACTION ALERT: Elevance Health, Inc. Investors With Losses Are Notified to Contact BFA Law About The Securities Fraud Class Action Lawsuit
NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.
Neutral
PRNewsWire
2 days ago
Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES , June 12, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV). IF YOU SUFFERED A LOSS ON YOUR ELEVANCE INVESTMENTS, CLICK HERE BEFORE JULY 11, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
Charts implemented using Lightweight Charts™